Target intelligence / Profile preview

Escherichia coli K88ab fimbrial antigen (K88ab)

Target
K88ab
Molecular classification
Bacterial adhesin, Fimbrial protein, Surface antigen, Lectin
01

Overview

The Escherichia coli K88ab fimbrial antigen, also known as the F4ab adhesin, is a critical virulence factor found on the surface of enterotoxigenic Escherichia coli (ETEC) strains that primarily infect swine [1, 2]. These fimbriae are long, filamentous proteinaceous appendages composed of subunits, most notably the major subunit FaeG, which mediates the attachment of the bacteria to specific glycoprotein receptors on the brush border of porcine intestinal epithelial cells [2, 12]. This adhesion is the essential first step in the pathogenesis of neonatal and post-weaning diarrhea, allowing the bacteria to colonize the small intestine and deliver enterotoxins [1, 13]. Because of its pivotal role in infection, the K88ab antigen is a major target for the development of veterinary vaccines and passive immunization strategies [3, 7]. Therapeutic interventions, such as maternal vaccination or the administration of specific monoclonal antibodies, aim to block this adhesive interaction, thereby preventing colonization and the resulting clinical disease [5, 13]. The antigen exists in several variants (ab, ac, and ad), which presents a challenge for broad-spectrum vaccine efficacy due to immunological heterogeneity among the different serotypes [2, 15].

Other names
F4ab fimbrial adhesinK88ab antigenFaeG major subunitK88 pilinF4ab antigenK88 fimbrial protein AB
02

Mechanism of action

The primary mechanism of action involves the induction of neutralizing antibodies (IgA and IgG) or the use of competitive inhibitors to block the binding of the fimbrial adhesin to host intestinal receptors, thereby preventing bacterial colonization and subsequent enterotoxin-mediated diarrhea [1, 5, 13].

03

Biological functions

Cell adhesionBacterial colonizationIntestinal attachmentBiofilm formation
04

Disease associations

InfectionPost-weaning diarrheaNeonatal diarrheaColibacillosis
05

Safety considerations

Antigenic variation (ab, ac, ad variants)Immunological heterogeneityVaccine-induced stress in livestockPotential for cross-reactivity
06

Interacting drugs

Gletvax 6

4 more in the full profile.

07

Biomarkers

Anti-K88ab IgG titersAnti-K88ab IgA titersK88ab-positive E. coli detection

Beyond the preview

Go deeper on Escherichia coli K88ab fimbrial antigen (K88ab).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Escherichia coli K88ab fimbrial antigen (K88ab).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call